Posted On: 07/17/2014 7:14:16 PM
Post# of 30034
Re: Loco motion #2111
Loco: I think things changed when AMBS secured the rights to Version 2 of LymPro. I think they were planning on doing a larger test in Q2 2014, but once they got version 2 I think they scuttled that big test in favor of doing this smaller 72 man "bridge test" comparing version 1 with 2. That's probably why they didn't announced the sens & spec numbers in Copenhagen. Gerald has said we'll have sens and spec numbers from the "bridge" study by July 31st.
Once we get into the LymPro partner's CLIA lab, another larger test is going to be done to validate the new partner can do what BD did. That could happen by August and commercialization by November.
I think some of my confusion came because version 2 changed things from what Gerald told me personally in Santa Monica. But I'm feeling good now in that I understand better what is going on.
I hope my probing didn't annoy too many people. Hopefully others benefited by it as well. The purpose of the mb is to do dd.
Once we get into the LymPro partner's CLIA lab, another larger test is going to be done to validate the new partner can do what BD did. That could happen by August and commercialization by November.
I think some of my confusion came because version 2 changed things from what Gerald told me personally in Santa Monica. But I'm feeling good now in that I understand better what is going on.
I hope my probing didn't annoy too many people. Hopefully others benefited by it as well. The purpose of the mb is to do dd.
(0)
(0)Scroll down for more posts ▼
